UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Profund Advisors LLC

Profund Advisors LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,454 shares of the healthcare conglomerate’s stock after selling 324 shares during the quarter. Profund Advisors LLC’s holdings in UnitedHealth Group were worth $9,398,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in UNH. Macroview Investment Management LLC boosted its holdings in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the period. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $31,000. Delos Wealth Advisors LLC raised its holdings in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Finally, Signature Resources Capital Management LLC grew its stake in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $575.00 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The stock has a market capitalization of $529.22 billion, a price-to-earnings ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58. The business’s 50 day moving average is $577.10 and its two-hundred day moving average is $520.80.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted $6.14 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Analyst Ratings Changes

Several research analysts have recently issued reports on UNH shares. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. HSBC upped their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, September 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Monday, September 16th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $614.17.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.